Origin: Synthetic peptide analog of Growth Hormone Releasing Hormone (GHRH)
Intended Use: For laboratory and research purposes only
What is CJC-1295?
CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH). It was engineered to increase the half-life of natural GHRH by binding to albumin, resulting in extended GH release. Due to this stability, CJC-1295 has become a subject of interest in research on growth hormone regulation, metabolic health, and healthy aging.
Potential Benefits in Research
Extended Growth Hormone Release Provides a long-acting stimulation of GH secretion compared to natural GHRH or shorter analogs.
IGF-1 Elevation Promotes sustained increases in IGF-1 levels, relevant for research on tissue growth and repair.
Muscle and Bone Research Explored in studies of muscle mass preservation, bone density, and regeneration.
Metabolic Health Potential effects on fat metabolism, insulin sensitivity, and energy balance.
Longevity Studies Its role in regulating the GH/IGF-1 axis makes it a valuable tool in aging and regenerative research.
Legal Notice and Disclaimer
For Research Purposes Only: Not intended for human consumption.
FDA Status: This product has not been evaluated or approved by the U.S. Food and Drug Administration (FDA).
WADA Classification: May be listed as a banned substance by the World Anti-Doping Agency (WADA).
Product Details
Packaging: 5 mg lyophilized powder in sterile glass vial
Storage: Store at 2–8 °C (refrigerated)
Solubility: Soluble in sterile water or bacteriostatic water
Use After Reconstitution: It is recommended to use shortly after preparation
Scientific References
Teichman, S. L. et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism.https://doi.org/10.1210/jc.2006-0209
Rahim, A. et al. (1996). Comparison of the pharmacokinetics and pharmacodynamics of GHRH and its analogs. Journal of Clinical Endocrinology & Metabolism.
Frohman, L. A. (2009). Regulation of growth hormone synthesis and secretion. Endocrinology and Metabolism Clinics of North America.
Contact & Orders
At TFLL Pharma, we are committed to providing research-grade peptides with the highest purity and quality. For more information or to order CJC-1295 2 mg, please contact us.
Note: This product is strictly for research purposes. Use must comply with local laws and ethical research standards.
